Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Bristol Myers Squibb, Cellvax, Cidar, Eilean, Halozyme, Hutchmed, Inmune, Gilead, Kite, Lexaria, Microbion, Neoimmunetech, Pfizer, Revolo, Takeda.